Functional defects of peripheral regulatory T lymphocytes in patients with progressive vitiligo

Pigment Cell and Melanoma Research

Volumn 25, Issue 1, 2012, Pages 99-109

  Ben Ahmed, M ^a,b   Zaraa, I ^b,c   Rekik, R ^a   Elbeldi Ferchiou, A ^a,c   Kourda, N ^a,d   Belhadj Hmida, N ^a   Abdeladhim, M ^a   Karoui, O ^a,c   Ben Osman, A ^b,c   Mokni, M ^b,c   Louzir, H ^a,b  

^a PASTEUR INSTITUTE OF TUNIS   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

^c LA RABTA HOSPITAL   (Tunisia)

^d CHARLES NICOLLE HOSPITAL   (Tunisia)

Author keywords

Forkhead box P3; Immune tolerance; Pathogenesis; Regulatory T cells; Vitiligo

Indexed keywords

TRANSCRIPTION FACTOR FOXP3;

ADOLESCENT; ADULT; AGED; ARTICLE; CD3+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELLULAR IMMUNODEFICIENCY; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE ASSOCIATION; FEMALE; HUMAN; HUMAN CELL; LYMPHOCYTE SUBPOPULATION; MALE; PATHOGENESIS; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; VITILIGO;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD3; AUTOIMMUNE DISEASES; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DISEASE PROGRESSION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; MALE; MELANOCYTES; MIDDLE AGED; MODELS, IMMUNOLOGICAL; RNA, MESSENGER; SELF TOLERANCE; T-LYMPHOCYTES, CYTOTOXIC; T-LYMPHOCYTES, REGULATORY; VITILIGO; YOUNG ADULT;

EID: 83955165876     PISSN: 17551471     EISSN: 1755148X     Source Type: Journal    
DOI: 10.1111/j.1755-148X.2011.00920.x     Document Type: Article

References (64)

1. Abdel-Naser, M.B., Ludwig, W.D., Gollnick, H., and Orfanos, C.E. (1992). Nonsegmental vitiligo: decrease of the CD45RA+ T-cell subset and evidence for peripheral T-cell activation. Int. J. Dermatol. 31, 321-326.
2. Alajlan, A., Alfadley, A., and Pedersen, K.T. (2002). Transfer of vitiligo after allogeneic bone marrow transplantation. J. Am. Acad. Dermatol. 46, 606-610.
3. Antiga, E., Quaglino, P., Bellandi, S. et al. (2010). Regulatory T cells in the skin lesions and blood of patients with systemic sclerosis and morphoea. Br. J. Dermatol. 162, 1056-1063.
4. Badri, A.M., Todd, P.M., Garioch, J.J., Gudgeon, J.E., Stewart, D.G., and Goudie, R.B. (1993). An immunohistological study of cutaneous lymphocytes in vitiligo. J. Pathol. 170, 149-155.
5. + regulatory cells from human peripheral blood express very high levels of CD25 ex vivo. Novartis Found. Symp. 252, 67-88; discussion 88-91, 106-114.
6. Ben Ahmed, M., Belhadj Hmida, N., Moes, N., Buyse, S., Abdeladhim, M., Louzir, H., and Cerf-Bensussan, N. (2009). IL-15 renders conventional lymphocytes resistant to suppressive functions of regulatory T cells through activation of the phosphatidylinositol 3-kinase pathway. J. Immunol. 182, 6763-6770.
7. Bennett, C.L., Christie, J., Ramsdell, F., Brunkow, M.E., Ferguson, P.J., Whitesell, L., Kelly, T.E., Saulsbury, F.T., Chance, P.F., and Ochs, H.D. (2001). The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat. Genet. 27, 20-21.
8. Bernard, F., Romano, A., and Granel, B. (2010). [Regulatory T cells and systemic autoimmune diseases: systemic lupus erythematosus, rheumatoid arthritis, primary Sjogren's syndrome]. Rev. Med. Interne 31, 116-127.
9. Birch, K.E., Vukmanovic-Stejic, M., Reed, J.R., Akbar, A.N., and Rustin, M.H. (2005). The immunomodulatory effects of regulatory T cells: implications for immune regulation in the skin. Br. J. Dermatol. 152, 409-417.
10. + T cells in normal skin and inflammatory dermatoses. J. Histochem. Cytochem. 55, 891-898.
11. Boissy, R.E., and Manga, P. (2004). On the etiology of contact/occupational vitiligo. Pigment Cell Res. 17, 208-214.
12. Brunkow, M.E., Jeffery, E.W., Hjerrild, K.A., Paeper, B., Clark, L.B., Yasayko, S.A., Wilkinson, J.E., Galas, D., Ziegler, S.F., and Ramsdell, F. (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat. Genet. 27, 68-73.
13. Casp, C.B., She, J.X., and McCormack, W.T. (2002). Genetic association of the catalase gene (CAT) with vitiligo susceptibility. Pigment Cell Res. 15, 62-66.
14. + regulatory T cells in patients with chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 13, 54-63.
15. D'Amelio, R., Frati, C., Fattorossi, A., and Aiuti, F. (1990). Peripheral T-cell subset imbalance in patients with vitiligo and in their apparently healthy first-degree relatives. Ann. Allergy 65, 143-145.
16. Dammak, I., Boudaya, S., Ben Abdallah, F., Turki, H., Attia, H., and Hentati, B. (2009). Antioxidant enzymes and lipid peroxidation at the tissue level in patients with stable and active vitiligo. Int. J. Dermatol. 48, 476-480.
17. Dell'anna, M.L., and Picardo, M. (2006). A review and a new hypothesis for non-immunological pathogenetic mechanisms in vitiligo. Pigment Cell Res. 19, 406-411.
18. Denman, C.J., McCracken, J., Hariharan, V., Klarquist, J., Oyarbide-Valencia, K., Guevara-Patino, J.A., and Le Poole, I.C. (2008). HSP70i accelerates depigmentation in a mouse model of autoimmune vitiligo. J. Invest. Dermatol. 128, 2041-2048.
19. + T cells with regulatory properties from human blood. J. Exp. Med. 193, 1303-1310.
20. + regulatory T cells. Nat. Immunol. 4, 330-336.
21. Gauthier, Y., Cario Andre, M., and Taieb, A. (2003a). A critical appraisal of vitiligo etiologic theories. Is melanocyte loss a melanocytorrhagy?. Pigment Cell Res. 16, 322-332.
22. Gauthier, Y., Cario-Andre, M., Lepreux, S., Pain, C., and Taieb, A. (2003b). Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo. Br. J. Dermatol. 148, 95-101.
23. Hann, S.K., Park, Y.K., Lee, K.G., Choi, E.H., and Im, S. (1992). Epidermal changes in active vitiligo. J. Dermatol. 19, 217-222.
24. Hann, S.K., Park, Y.K., Chung, K.Y., Kim, H.I., Im, S., and Won, J.H. (1993). Peripheral blood lymphocyte imbalance in Koreans with active vitiligo. Int. J. Dermatol. 32, 286-289.
25. + regulatory T cells bear functional skin-homing receptors. J. Immunol. 177, 4488-4494.
26. Hori, S., Nomura, T., and Sakaguchi, S. (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299, 1057-1061.
27. Jager, E., Maeurer, M., Hohn, H. et al. (2000). Clonal expansion of Melan A-specific cytotoxic T lymphocytes in a melanoma patient responding to continued immunization with melanoma-associated peptides. Int. J. Cancer 86, 538-547.
28. + T cells with regulatory properties isolated from peripheral blood. J. Exp. Med. 193, 1285-1294.
29. Klarquist, J., Denman, C.J., Hernandez, C., Wainwright, D.A., Strickland, F.M., Overbeck, A., Mehrotra, S., Nishimura, M.I., and Le Poole, I.C. (2010). Reduced skin homing by functional Treg in vitiligo. Pigment Cell Melanoma Res. 23, 276-286.
30. + regulatory T cells in autoimmune polyglandular syndrome type II. J. Exp. Med. 199, 1285-1291.
31. Kukreja, A., Cost, G., Marker, J. et al. (2002). Multiple immuno-regulatory defects in type-1 diabetes. J. Clin. Invest. 109, 131-140.
32. Laberge, G., Mailloux, C.M., Gowan, K., Holland, P., Bennett, D.C., Fain, P.R., and Spritz, R.A. (2005). Early disease onset and increased risk of other autoimmune diseases in familial generalized vitiligo. Pigment Cell Res. 18, 300-305.
33. + T lymphocytes detected in vitiligo patients are related to disease activity and are predominantly directed against MelanA/MART1. J. Invest. Dermatol. 116, 891-897.
34. Le Poole, I.C., and Luiten, R.M. (2008). Autoimmune etiology of generalized vitiligo. Curr. Dir. Autoimmun. 10, 227-243.
35. Le Poole, I.C., Das, P.K., van den Wijngaard, R.M., Bos, J.D., and Westerhof, W. (1993). Review of the etiopathomechanism of vitiligo: a convergence theory. Exp. Dermatol. 2, 145-153.
36. Le Poole, I.C., van den Wijngaard, R.M., Westerhof, W., and Das, P.K. (1996). Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance. Am. J. Pathol. 148, 1219-1228.
37. Maeda, A., Beissert, S., Schwarz, T., and Schwarz, A. (2008). Phenotypic and functional characterization of ultraviolet radiation-induced regulatory T cells. J. Immunol. 180, 3065-3071.
38. Mahmoud, F., Abul, H., Al-Saleh, Q., Haines, D., Burleson, J., and Morgan, G. (1998). Peripheral T-cell activation in non-segmental vitiligo. J. Dermatol. 25, 637-640.
39. + of T-helper cells in non-segmental vitiligo. J. Dermatol. 29, 68-73.
40. Mazereeuw-Hautier, J., Bezio, S., Mahe, E. et al. (2010). Segmental and nonsegmental childhood vitiligo has distinct clinical characteristics: a prospective observational study. J. Am. Acad. Dermatol. 62, 945-949.
41. Miyara, M., Amoura, Z., Parizot, C., Badoual, C., Dorgham, K., Trad, S., Nochy, D., Debre, P., Piette, J.C., and Gorochov, G. (2005). Global natural regulatory T cell depletion in active systemic lupus erythematosus. J. Immunol. 175, 8392-8400.
42. Namazi, M.R. (2007). Neurogenic dysregulation, oxidative stress, autoimmunity, and melanocytorrhagy in vitiligo: can they be interconnected? Pigment Cell Res. 20, 360-363.
43. Neumeister, P., Strunk, D., Apfelbeck, U., Sill, H., and Linkesch, W. (2000). Adoptive transfer of vitiligo after allogeneic bone marrow transplantation for non-Hodgkin's lymphoma. Lancet 355, 1334-1335.
44. Ogg, G.S., Rod Dunbar, P., Romero, P., Chen, J.L., and Cerundolo, V. (1998). High frequency of skin-homing melanocyte-specific cytotoxic T lymphocytes in autoimmune vitiligo. J. Exp. Med. 188, 1203-1208.
45. Ongenae, K., Van Geel, N., and Naeyaert, J.M. (2003). Evidence for an autoimmune pathogenesis of vitiligo. Pigment Cell Res. 16, 90-100.
46. Palermo, B., Campanelli, R., Garbelli, S. et al. (2001). Specific cytotoxic T lymphocyte responses against Melan-A/MART1, tyrosinase and gp100 in vitiligo by the use of major histocompatibility complex/peptide tetramers: the role of cellular immunity in the etiopathogenesis of vitiligo. J. Invest. Dermatol. 117, 326-332.
47. Roopashree, M.R., Gondhalekar, R.V., Shashikanth, M.C., George, J., Thippeswamy, S.H., and Shukla, A. (2010). Pathogenesis of oral lichen planus - a review. J. Oral Pathol. Med. 39, 729-734.
48. + regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6, 345-352.
49. Schallreuter, K.U., Wood, J.M., and Berger, J. (1991). Low catalase levels in the epidermis of patients with vitiligo. J. Invest. Dermatol. 97, 1081-1085.
50. Scheibenbogen, C., Hunstein, W., and Keilholz, U. (1994). Vitiligo-like lesions following immunotherapy with IFN alpha and IL-2 in melanoma patients. Eur. J. Cancer 30A, 1209-1211.
51. Schwarz, T. (2008). 25years of UV-induced immunosuppression mediated by T cells - from disregarded T suppressor cells to highly respected regulatory T cells. Photochem. Photobiol. 84, 10-18.
52. Spritz, R.A. (2007). The genetics of generalized vitiligo and associated autoimmune diseases. Pigment Cell Res. 20, 271-278.
53. +T cells recognizing melanocytic antigens in the epidermis: implications for the pathophysiology of vitiligo. Eur. J. Cell Biol. 83, 797-803.
54. + T cells and local inflammation: implications for the pathophysiology of vitiligo. J. Invest. Dermatol. 124, 144-150.
55. Taieb, A., and Picardo, M. (2007). The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 20, 27-35.
56. Taieb, A., and Picardo, M. (2009). Clinical practice. Vitiligo. N. Engl. J. Med. 360, 160-169.
57. Taieb, A., Morice-Picard, F., Jouary, T., Ezzedine, K., Cario-Andre, M., and Gauthier, Y. (2008). Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo. Pigment Cell Melanoma Res. 21, 646-652.
58. + immunoregulatory T cells is antigen nonspecific. J. Immunol. 164, 183-190.
59. + regulatory T cells in patients with multiple sclerosis. J. Exp. Med. 199, 971-979.
60. Vorobjova, T., Uibo, O., Heilman, K., Rago, T., Honkanen, J., Vaarala, O., Tillmann, V., Ojakivi, I., and Uibo, R. (2009). Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus. Scand. J. Gastroenterol. 44, 422-430.
61. Westerhof, W., and D'Ischia, M. (2007). Vitiligo puzzle: the pieces fall in place. Pigment Cell Res. 20, 345-359.
62. + regulatory T cells. Int. Immunol. 16, 1643-1656.
63. Yee, C., Thompson, J.A., Roche, P., Byrd, D.R., Lee, P.P., Piepkorn, M., Kenyon, K., Davis, M.M., Riddell, S.R., and Greenberg, P.D. (2000). Melanocyte destruction after antigen-specific immunotherapy of melanoma: direct evidence of t cell-mediated vitiligo. J. Exp. Med. 192, 1637-1644.
64. Zheng, Y., and Rudensky, A.Y. (2007). Foxp3 in control of the regulatory T cell lineage. Nat. Immunol. 8, 457-462.